Verve Therapeutics

North America Legal Chronicle. November 7, 2023

Verve Therapeutics’ Relationship Expansion with Lilly

By Leila Ahmed

Wilson Sonsini Goodrich & Rosati advised Verve Therapeutics on IP matters related to the transaction. Verve Therapeutics, Inc. (Nasdaq:VERV) announced the expansion of its relationship with Eli Lilly...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

North America Legal Chronicle. June 20, 2023

Verve Therapeutics’ Collaboration Agreement with Lilly

By Leila Ahmed

Wilson Sonsini Goodrich & Rosati advised Verve on IP matters related to the transaction. Verve Therapeutics, Inc., a clinical-stage genetic medicines company, announced an exclusive research collaboration...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

North America Legal Chronicle. July 26, 2022

Verve Therapeutics’ $225 Million Shares Public Offering

By Martina Bellini

Wilson Sonsini Goodrich & Rosati advised Verve Therapeutics on the deal. Verve Therapeutics, a biotechnology company pioneering a new approach to the care of cardiovascular disease...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

North America. North America Legal Chronicle. June 19, 2021

Verve Therapeutics’ $306 Million IPO

By Martina Bellini

Wilson Sonsini Goodrich & Rosati advised Verve Therapeutics on the deal. Verve Therapeutics (Nasdaq: VERV), a biotech company pioneering a new approach to the care of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

GameAbove Sports’ Acquisition of Ownership Stake in Brisbane Bullets

Lee Health’s Conversion to Private, Nonprofit Health System

Green Theme Technologies’ $6 Million Series C Financing Round

MS Private Credit Administrative Services’ $20 Million Investment in Novopayment

Ivi Energia’s R$150 Million Debentures Issuance

CNH Industrial Capital Argentina’s US$28 Million Notes Issuance

SYNCPILOT Group’s Financing Round With Pictet

MIGx AG’s Partnership Agreement with GREENPEAK Partners

LVMH’s Acquisition of a Minority Stake in Our Legacy

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Camusat Holding’s €81 Million Mezzanine Investment Round

Retail Holding’s Shareholders Reconfiguration

Rönesans Holding’s €456 Million Healthcare Project in Kazakhstan

Turkey Wealth Fund’s Sukuk Issuance

ADQ’s Acquisition of Odea Bank

Cello World’s Merger with Wim Plast

Intudo’s US$125 Million Closing of Intudo Ventures IV and Natural Resources Fund

Downhole Products Limited’s Acquisition of Sledgehammer Oil Tools Private Limited

Aloke Chakravarty Joins Saul Ewing’s Boston Office

Demarest announces new Dispute Resolution partner

Venture Financing Partner N. Danny Shulman Joins Honigman in Washington

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

Aloke Chakravarty Joins Saul Ewing’s Boston Office

Demarest announces new Dispute Resolution partner

Venture Financing Partner N. Danny Shulman Joins Honigman in Washington

Verve Therapeutics’ Relationship Expansion with Lilly

Standard 1 Year Membership Required

Verve Therapeutics’ Collaboration Agreement with Lilly

Standard 1 Year Membership Required

Verve Therapeutics’ $225 Million Shares Public Offering

Standard 1 Year Membership Required

Verve Therapeutics’ $306 Million IPO

Standard 1 Year Membership Required